QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$42.68 USD
-1.20 (-2.73%)
Updated May 8, 2024 04:00 PM ET
After-Market: $42.00 -0.68 (-1.59%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
QDEL 42.68 -1.20(-2.73%)
Will QDEL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for QDEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QDEL
Here's What Key Metrics Tell Us About QuidelOrtho (QDEL) Q1 Earnings
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
QDEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Unveiling QuidelOrtho (QDEL) Q1 Outlook: Wall Street Estimates for Key Metrics
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
Other News for QDEL
QuidelOrtho: Q1 Earnings Snapshot
QuidelOrtho Reports First Quarter 2024 Financial Results
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024
QuidelOrtho Corporation (QDEL) Q1 2024 Earnings Call Transcript
QuidelOrtho Corporation 2024 Q1 - Results - Earnings Call Presentation